Trial findings support 3 months of blood thinners, rather than 12 months, in patients after myocardial infarction
Three months of dual antiplatelet therapy (DAPT) was associated with signals suggesting improved survival and lower bleeding risk than 12 months of DAPT, in a real-world all-comer population of patients with myocardial infarction ...
Sep 1, 2025
0
0